Media Pack
News

Current Edition

Volume 7 Issue 3

Upcoming Events

 

Advertisement

 
 
 
 
A World Leader in Naturally Derived Products Discusses Commercial Success and New Innovations
Volume 4 Issue 2

A World Leader in Naturally Derived Products Discusses Commercial Success and New Innovations

Mr. Darren Alkins CEO at SPL – Scientific Protein Laboratories, speaks with IBI about their continued development in their science and technical expertise to meet the...
8 July 2021 Volume 4 Issue 2
Continue Reading →
Supporting Mergers and Acquisitions in the Pharmaceutical/Biopharmaceutical Industry
Volume 4 Issue 2

Supporting Mergers and Acquisitions in the Pharmaceutical/Biopharmaceutical Industry

In recent years, we have seen pharmaceutical company megadeals that saw Takeda acquiring Shire for a total value of $81.7 billion, Bristol-Myers Squibb’s acquisition ...
8 July 2021 Volume 4 Issue 2
Continue Reading →
Dealing with the Challenges of Post-translational Modifications (PTMs)
Volume 4 Issue 2

Dealing with the Challenges of Post-translational Modifications (PTMs)

During the structural analysis of recombinant protein biopharmaceutical products, a significant challenge is posed by the issue of Post Translational Modifications (P...
8 July 2021 Volume 4 Issue 2
Continue Reading →
Solving Critical Data Challenges for Chemicallymodified, Biologically-based Therapeutic Candidates
Volume 4 Issue 2

Solving Critical Data Challenges for Chemicallymodified, Biologically-based Therapeutic Candidates

The drug discovery research industry is seeing a growing prevalence of chemically-modified, biologically-based therapeutic candidates. This trend creates urgent and n...
8 July 2021 Volume 4 Issue 2
Continue Reading →
Using Lentiviral Vectors to Advance the Development of Therapeutic Vaccines
Volume 4 Issue 2

Using Lentiviral Vectors to Advance the Development of Therapeutic Vaccines

Traditionally, vaccination has been used as a preventative strategy, aimed at curbing the impact of a wide range of infectious diseases. Over the past three decades, ...
8 July 2021 Volume 4 Issue 2
Continue Reading →
Antibody-drug Conjugates: A Trojan Horse Story
Volume 4 Issue 2

Antibody-drug Conjugates: A Trojan Horse Story

According to the World Health Organization, cancer is responsible for 10 million deaths per year, and it is considered as the second leading cause of death in the wor...
8 July 2021 Volume 4 Issue 2
Continue Reading →
Adapting Your Preclinical Animal Model Strategies for a New World
Volume 4 Issue 2

Adapting Your Preclinical Animal Model Strategies for a New World

Investigators in the commercial and non-profit sectors have always faced pressure to accelerate their work while balancing the need for quality and the realities of b...
8 July 2021 Volume 4 Issue 2
Continue Reading →
Standard vs. Hybrid FIH Trials: Advantages and Challenges
Volume 4 Issue 2

Standard vs. Hybrid FIH Trials: Advantages and Challenges

First in human (FIH) studies are the key translational studies from preclinical to further clinical development processes. The goal of FIH studies is to investigate p...
8 July 2021 Volume 4 Issue 2
Continue Reading →
Intricacies and Future Considerations for the Cell and Gene Therapy Cold Chain
Volume 4 Issue 2

Intricacies and Future Considerations for the Cell and Gene Therapy Cold Chain

The rapidly growing field of cell and gene therapy is both exciting and confusing to many, including those who work in the medical community and on the periphery. Adv...
8 July 2021 Volume 4 Issue 2
Continue Reading →
Four Factors for a Biopharmaceutical Manufacturer to Consider when Developing and Managing a Single-use Supply Chain
Volume 4 Issue 2

Four Factors for a Biopharmaceutical Manufacturer to Consider when Developing and Managing a Single-use Supply Chain

Single-use technologies are becoming widely utilised in the biopharmaceutical industry for the benefit of offering a more flexible, cost-effective approach to cGMP ma...
8 July 2021 Volume 4 Issue 2
Continue Reading →
 
 
 
 
IBI-white.png

International Biopharmaceutical Industry

IBI – International Biopharmaceutical Industry was established to fill in the void for effective marketing and communication between all stakeholders in the Life sciences sector globally.

Facebook Linkedin
Bio Pharmaceutical Media © 2024, All Rights Reserved – Powered by Teksyte